Epilepsy, characterized by recurrent seizures, is a neurological disorder with significant psychiatric implications. From mood disturbances to cognitive challenges, understanding the broader impact of epilepsy is crucial. The Journal of Clinical Psychiatry provides comprehensive insights into the psychiatric aspects of epilepsy, offering evidence-based therapeutic approaches and the latest research findings. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care to individuals with epilepsy.
Epilepsy
Recently published articles about Epilepsy
Case Report
Mesial Temporal Sclerosis and Juvenile Myoclonic Epilepsy
March 26, 2026
The authors present a rare case of coexisting right mesial temporal sclerosis and juvenile myoclonic epilepsy, underscoring the challenges in dual epilepsy syndromes and the importance of individualized, multidisciplinary...
Case Report
ECT for Catatonia With NPSLE, Epilepsy, and Cerebral Palsy
July 25, 2024
An 18-year-old patient with neuropsychiatric systemic lupus erythematosus, epilepsy, and cerebral palsy who developed benzodiazepine-refractory catatonia and immunosuppression experienced complete resolution of symptoms after 20 ECT treatments.
Clinical and Practical Psychopharmacology
Epilepsy, Antiepileptic Drugs, and Adverse Pregnancy Outcomes, 2: Major Congenital Malformations
July 3, 2024
This article reviews evidence from a large registry, a population-based study, and a meta-analysis on the risks of major congenital malformation with untreated epilepsy and with exposure to antiepileptic...
Clinical and Practical Psychopharmacology
Epilepsy, Antiepileptic Drugs, and Adverse Pregnancy Outcomes, 1: Recent Research
June 5, 2024
This article provides women who have epilepsy and who use antiepileptic drugs during pregnancy with information about the many risks to which they and their fetus/neonate are exposed at...
Recent JCP Articles on Epilepsy
Video Abstract
Population Pharmacokinetics and Dosing Simulations for Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder
September 18, 2026
Jonathan M. Meyer, MD, and Leslie Citrome, MD, present a JCP video abstract on pharmacokinetic simulations for paliperidone palmitate 351 mg, and what its every-4, -6, and -8-week dosing...
Original Research
Bilateral tDCS Reduces Relief Craving During Alcohol Withdrawal
September 17, 2026
Ten sessions of bilateral transcranial direct current stimulation over the dorsolateral prefrontal cortex applied during the active withdrawal period and not modified by dependence severity significantly reduced relief craving...
Recent PCC Articles on Epilepsy
Featured Epilepsy Research
Insights
▶ Video
Paliperidone Palmitate 351 mg as Alternative Maintenance Doses in Patients With Schizophrenia or Schizoaffective Disorder
September 16, 2026
This analysis suggests that maintenance doses of paliperidone palmitate 351 mg at different dosing intervals may offer additional treatment options for clinical use.
